| | | | | |
| $43.8800 | -4.98 % | $292.68M | $18.06K | |
NUCL Eagle Nuclear Energy Corp. Common stock | $8.8800 | -7.11 % | $292.53M | $328.68K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10.8700 | +0.37 % | $292.20M | $209.63K | |
FWDI Forward Industries, Inc. Common Stock | $4.7900 | +1.92 % | $292.06M | $2.24M | |
ELDN Eledon Pharmaceuticals, Inc. Common Stock | $3.9450 | +1.15 % | $291.76M | $1.16M | |
| $10.2700 | +1.89 % | $291.70M | $946.56K | |
SVAQ Silicon Valley Acquisition Corp. Class A Ordinary Shares | $10.1100 | +0.20 % | $291.56M | $39.41K | |
WNEB Western New England Bancorp, Inc. | $14.4600 | -1.43 % | $291.41M | $41.00K | |
| $7.7400 | -0.39 % | $291.40M | $99.71K | |
PACH Pioneer Acquisition I Corp Class A Ordinary Shares | $10.2400 | +0.00 % | $291.22M | $398.00 | |
MMD NYLI MacKay DefinedTerm Muni Opportunities Fund | $15.4700 | +0.00 % | $291.08M | $33.54K | |
AENT Alliance Entertainment Holding Corporation Class A Common Stock | $5.9400 | +2.59 % | $291.06M | $14.74K | |
GLSI Greenwich LifeSciences, Inc. | $22.0800 | -6.84 % | $290.62M | $101.56K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3.9200 | +1.03 % | $290.56M | $266.61K | |
TLSI TriSalus Life Sciences, Inc. Common Stock | $4.6950 | +5.27 % | $290.50M | $220.99K | |
